Name: Harborview offers another new medication for early-stage Alzheimer's patients: HealthLink
Channel: TEGNA
Description: The FDA-approved monoclonal antibody infusion known as donanemab, is showing promise to reduce cognitive decline among early-onset patients.

Kurator

For Seller Marketplace

Request License

> Media Pool

> Harborview offers another new medication for early-stage Alzheimer's patients: HealthLink

Harborview offers another new medication for early-stage Alzheimer's patients: HealthLink

Clip ID 2504661

Clearance

Add to

By Request

By Request assets are not available for immediate purchase.

This content has not been pre-checked for copyright.

Per clip rates are for 20 seconds of final usage. If you are using more then 20 seconds or need a different file format or have questions about clearances contact us

Description

The FDA-approved monoclonal antibody infusion known as donanemab, is showing promise to reduce cognitive decline among early-onset patients.

Station

KING

Keywords

health news

Related Footage